Literature DB >> 34002083

Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.

Alison P Klein1.   

Abstract

Pancreatic cancer is a leading cause of cancer death worldwide and its global burden has more than doubled over the past 25 years. The highest incidence regions for pancreatic cancer include North America, Europe and Australia, and although much of this increase is due to ageing worldwide populations, there are key modifiable risk factors for pancreatic cancer such as cigarette smoking, obesity, diabetes and alcohol intake. The prevalence of these risk factors is increasing in many global regions, resulting in increasing age-adjusted incidence rates for pancreatic cancer, but the relative contribution from these risk factors varies globally due to variation in the underlying prevalence and prevention strategies. Inherited genetic factors, although not directly modifiable, are an important component of pancreatic cancer risk, and include pathogenic variants in hereditary cancer genes, genes associated with hereditary pancreatitis, as well as common variants identified in genome-wide association studies. Identification of the genetic changes that underlie pancreatic cancer not only provides insight into the aetiology of this cancer but also provides an opportunity to guide early detection strategies. The goal of this Review is to provide an up-to-date overview of the established modifiable and inherited risk factors for pancreatic cancer.

Entities:  

Mesh:

Year:  2021        PMID: 34002083      PMCID: PMC9265847          DOI: 10.1038/s41575-021-00457-x

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   73.082


  149 in total

Review 1.  Occupational risk factors and pancreatic cancer: a review of recent findings.

Authors:  Gabriella Andreotti; Debra T Silverman
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  Tobacco and the risk of pancreatic cancer: a review and meta-analysis.

Authors:  Simona Iodice; Sara Gandini; Patrick Maisonneuve; Albert B Lowenfels
Journal:  Langenbecks Arch Surg       Date:  2008-01-12       Impact factor: 3.445

3.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Authors:  Dung T Le; Jennifer N Durham; Kellie N Smith; Hao Wang; Bjarne R Bartlett; Laveet K Aulakh; Steve Lu; Holly Kemberling; Cara Wilt; Brandon S Luber; Fay Wong; Nilofer S Azad; Agnieszka A Rucki; Dan Laheru; Ross Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Tim F Greten; Austin G Duffy; Kristen K Ciombor; Aleksandra D Eyring; Bao H Lam; Andrew Joe; S Peter Kang; Matthias Holdhoff; Ludmila Danilova; Leslie Cope; Christian Meyer; Shibin Zhou; Richard M Goldberg; Deborah K Armstrong; Katherine M Bever; Amanda N Fader; Janis Taube; Franck Housseau; David Spetzler; Nianqing Xiao; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; James R Eshleman; Bert Vogelstein; Robert A Anders; Luis A Diaz
Journal:  Science       Date:  2017-06-08       Impact factor: 47.728

4.  Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.

Authors:  Sara H Olson; Meier Hsu; Jaya M Satagopan; Patrick Maisonneuve; Debra T Silverman; Ersilia Lucenteforte; Kristin E Anderson; Ayelet Borgida; Paige M Bracci; H Bas Bueno-de-Mesquita; Michelle Cotterchio; Qi Dai; Eric J Duell; Elizabeth H Fontham; Steven Gallinger; Elizabeth A Holly; Bu-Tian Ji; Robert C Kurtz; Carlo La Vecchia; Albert B Lowenfels; Brian Luckett; Emmy Ludwig; Gloria M Petersen; Jerry Polesel; Daniela Seminara; Lori Strayer; Renato Talamini
Journal:  Am J Epidemiol       Date:  2013-07-02       Impact factor: 4.897

5.  Why do Black Americans have a higher risk of pancreatic cancer than White Americans?

Authors:  Debra T Silverman; Robert N Hoover; Linda M Brown; G Marie Swanson; Mark Schiffman; Raymond S Greenberg; Richard B Hayes; Keith D Lillemoe; Janet B Schoenberg; Ann G Schwartz; Jonathan Liff; Linda M Pottern; Joseph F Fraumeni
Journal:  Epidemiology       Date:  2003-01       Impact factor: 4.822

6.  A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer.

Authors:  Jun Zhong; Ashley Jermusyk; Lang Wu; Jason W Hoskins; Irene Collins; Evelina Mocci; Mingfeng Zhang; Lei Song; Charles C Chung; Tongwu Zhang; Wenming Xiao; Demetrius Albanes; Gabriella Andreotti; Alan A Arslan; Ana Babic; William R Bamlet; Laura Beane-Freeman; Sonja Berndt; Ayelet Borgida; Paige M Bracci; Lauren Brais; Paul Brennan; Bas Bueno-de-Mesquita; Julie Buring; Federico Canzian; Erica J Childs; Michelle Cotterchio; Mengmeng Du; Eric J Duell; Charles Fuchs; Steven Gallinger; J Michael Gaziano; Graham G Giles; Edward Giovannucci; Michael Goggins; Gary E Goodman; Phyllis J Goodman; Christopher Haiman; Patricia Hartge; Manal Hasan; Kathy J Helzlsouer; Elizabeth A Holly; Eric A Klein; Manolis Kogevinas; Robert J Kurtz; Loic LeMarchand; Núria Malats; Satu Männistö; Roger Milne; Rachel E Neale; Kimmie Ng; Ofure Obazee; Ann L Oberg; Irene Orlow; Alpa V Patel; Ulrike Peters; Miquel Porta; Nathaniel Rothman; Ghislaine Scelo; Howard D Sesso; Gianluca Severi; Sabina Sieri; Debra Silverman; Malin Sund; Anne Tjønneland; Mark D Thornquist; Geoffrey S Tobias; Antonia Trichopoulou; Stephen K Van Den Eeden; Kala Visvanathan; Jean Wactawski-Wende; Nicolas Wentzensen; Emily White; Herbert Yu; Chen Yuan; Anne Zeleniuch-Jacquotte; Robert Hoover; Kevin Brown; Charles Kooperberg; Harvey A Risch; Eric J Jacobs; Donghui Li; Kai Yu; Xiao-Ou Shu; Stephen J Chanock; Brian M Wolpin; Rachael Z Stolzenberg-Solomon; Nilanjan Chatterjee; Alison P Klein; Jill P Smith; Peter Kraft; Jianxin Shi; Gloria M Petersen; Wei Zheng; Laufey T Amundadottir
Journal:  J Natl Cancer Inst       Date:  2020-10-01       Impact factor: 13.506

7.  Cigarette, cigar and pipe smoking, passive smoke exposure, and risk of pancreatic cancer: a population-based study in the San Francisco Bay Area.

Authors:  Gregory J Tranah; Elizabeth A Holly; Furong Wang; Paige M Bracci
Journal:  BMC Cancer       Date:  2011-04-15       Impact factor: 4.430

8.  BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.

Authors:  David B Zhen; Kari G Rabe; Steven Gallinger; Sapna Syngal; Ann G Schwartz; Michael G Goggins; Ralph H Hruban; Michele L Cote; Robert R McWilliams; Nicholas J Roberts; Lisa A Cannon-Albright; Donghui Li; Kelsey Moyes; Richard J Wenstrup; Anne-Renee Hartman; Daniela Seminara; Alison P Klein; Gloria M Petersen
Journal:  Genet Med       Date:  2014-11-20       Impact factor: 8.822

9.  Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.

Authors:  Dominique S Michaud; Jacques Izard; Charlotte S Wilhelm-Benartzi; Doo-Ho You; Verena A Grote; Anne Tjønneland; Christina C Dahm; Kim Overvad; Mazda Jenab; Veronika Fedirko; Marie Christine Boutron-Ruault; Françoise Clavel-Chapelon; Antoine Racine; Rudolf Kaaks; Heiner Boeing; Jana Foerster; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Carlotta Sacerdote; Sabina Sieri; Domenico Palli; Rosario Tumino; Salvatore Panico; Peter D Siersema; Petra H M Peeters; Eiliv Lund; Aurelio Barricarte; José-María Huerta; Esther Molina-Montes; Miren Dorronsoro; J Ramón Quirós; Eric J Duell; Weimin Ye; Malin Sund; Björn Lindkvist; Dorthe Johansen; Kay-Tee Khaw; Nick Wareham; Ruth C Travis; Paolo Vineis; H Bas Bueno-de-Mesquita; Elio Riboli
Journal:  Gut       Date:  2012-09-18       Impact factor: 23.059

10.  Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Authors:  Brian M Wolpin; Cosmeri Rizzato; Peter Kraft; Charles Kooperberg; Gloria M Petersen; Zhaoming Wang; Alan A Arslan; Laura Beane-Freeman; Paige M Bracci; Julie Buring; Federico Canzian; Eric J Duell; Steven Gallinger; Graham G Giles; Gary E Goodman; Phyllis J Goodman; Eric J Jacobs; Aruna Kamineni; Alison P Klein; Laurence N Kolonel; Matthew H Kulke; Donghui Li; Núria Malats; Sara H Olson; Harvey A Risch; Howard D Sesso; Kala Visvanathan; Emily White; Wei Zheng; Christian C Abnet; Demetrius Albanes; Gabriella Andreotti; Melissa A Austin; Richard Barfield; Daniela Basso; Sonja I Berndt; Marie-Christine Boutron-Ruault; Michelle Brotzman; Markus W Büchler; H Bas Bueno-de-Mesquita; Peter Bugert; Laurie Burdette; Daniele Campa; Neil E Caporaso; Gabriele Capurso; Charles Chung; Michelle Cotterchio; Eithne Costello; Joanne Elena; Niccola Funel; J Michael Gaziano; Nathalia A Giese; Edward L Giovannucci; Michael Goggins; Megan J Gorman; Myron Gross; Christopher A Haiman; Manal Hassan; Kathy J Helzlsouer; Brian E Henderson; Elizabeth A Holly; Nan Hu; David J Hunter; Federico Innocenti; Mazda Jenab; Rudolf Kaaks; Timothy J Key; Kay-Tee Khaw; Eric A Klein; Manolis Kogevinas; Vittorio Krogh; Juozas Kupcinskas; Robert C Kurtz; Andrea LaCroix; Maria T Landi; Stefano Landi; Loic Le Marchand; Andrea Mambrini; Satu Mannisto; Roger L Milne; Yusuke Nakamura; Ann L Oberg; Kouros Owzar; Alpa V Patel; Petra H M Peeters; Ulrike Peters; Raffaele Pezzilli; Ada Piepoli; Miquel Porta; Francisco X Real; Elio Riboli; Nathaniel Rothman; Aldo Scarpa; Xiao-Ou Shu; Debra T Silverman; Pavel Soucek; Malin Sund; Renata Talar-Wojnarowska; Philip R Taylor; George E Theodoropoulos; Mark Thornquist; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Pavel Vodicka; Jean Wactawski-Wende; Nicolas Wentzensen; Chen Wu; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Robert Hoover; Patricia Hartge; Charles Fuchs; Stephen J Chanock; Rachael S Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Nat Genet       Date:  2014-08-03       Impact factor: 41.307

View more
  48 in total

Review 1.  A review of physical activity in pancreatic ductal adenocarcinoma: Epidemiology, intervention, animal models, and clinical trials.

Authors:  Hsiang-Yin Hsueh; Valentina Pita-Grisanti; Kristyn Gumpper-Fedus; Ali Lahooti; Myrriah Chavez-Tomar; Keri Schadler; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2021-10-26       Impact factor: 3.996

2.  Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database.

Authors:  Tingxi Wu; Yang Zhang; Yanfeng Shi; Kefu Yu; Mei Zhao; Shangyi Liu; Zhigang Zhao
Journal:  Clin Drug Investig       Date:  2022-09-30       Impact factor: 3.580

3.  An integrative approach for identification of smoking-related genes involving bladder cancer.

Authors:  Fang Gao; Huiqin Li; Zhenguang Mao; Yanping Xiao; Mulong Du; Shizhi Wang; Rui Zheng; Zhengdong Zhang; Meilin Wang
Journal:  Arch Toxicol       Date:  2022-10-12       Impact factor: 6.168

4.  Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.

Authors:  Wei Xu; Man Zhang; Lu Liu; Minyue Yin; Chunfang Xu; Zhen Weng
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

5.  Survival Analysis and Prediction Model of ASCP Based on SEER Database.

Authors:  Sun-Yuan Lv; Min-Jie Lin; Zhao-Qun Yang; Chen-Nan Xu; Zhi-Ming Wu
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

6.  A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma.

Authors:  Kai Zhao; Xiangyu Li; Yuanxin Shi; Yun Lu; Peng Qiu; Zhengdong Deng; Wei Yao; Jianming Wang
Journal:  Front Genet       Date:  2022-07-06       Impact factor: 4.772

7.  Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer.

Authors:  Lang Zhou; Zhaoshu Wu; Chunping Jiang; Shiming Dai
Journal:  Comput Math Methods Med       Date:  2022-06-18       Impact factor: 2.809

Review 8.  Understanding Necroptosis in Pancreatic Diseases.

Authors:  Ru He; Zhengfeng Wang; Shi Dong; Zhou Chen; Wence Zhou
Journal:  Biomolecules       Date:  2022-06-13

Review 9.  Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.

Authors:  Evangelos Koustas; Eleni-Myrto Trifylli; Panagiotis Sarantis; Nikolaos Papadopoulos; Eleni Karapedi; Georgios Aloizos; Christos Damaskos; Nikolaos Garmpis; Anna Garmpi; Kostas A Papavassiliou; Michalis V Karamouzis; Athanasios G Papavassiliou
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

10.  SIRT5's GOT1 up on PDAC.

Authors:  Surinder Kumar; David B Lombard
Journal:  Gastroenterology       Date:  2021-07-16       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.